Wirth is the CEO of Amida Care. Crowley is the director of the O’Neill Institute’s Center for HIV and Infectious Disease Policy at Georgetown Law. In June, a clinical trial showed that a twice-yearly ...

HIV (human immunodeficiency virus) remains a significant global health challenge, affecting millions of people worldwide. While advancements in medical science have led to better management of the ...

WASHINGTON, DC, UNITED STATES, December 4, 2024 /EINPresswire.com/ -- HealthHIV announces that its HIV PrEP Navigation Certification™ Program (HIVPNC) has been ...

With Gilead Sciences' stated focus to grow in oncology, the company's recent quarterly updates have placed a heavy emphasis on its developments in the cancer space. But, with a unique pre-exposure ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

Please provide your email address to receive an email when new articles are posted on . PrEP coverage in the U.S. between 2012-2021 ranged from 3.8% in West Virginia to 22.2% in New York. Australian ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

Partnering with Gilead, Ciara is using her music to encourage education, protection, and broader conversations around PrEP & HIV prevention.

When I, a heterosexual woman, visited clinics in Ann Arbor, I heard nothing about assessments for sexually transmitted infections screening or HIV antiretroviral pre-exposure prophylaxis. However, ...